DENVER--(BUSINESS WIRE)--June 8, 2006--Myogen, Inc. (Nasdaq: MYOG - News), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular disorders, today announced that J. William Freytag, President and CEO, will present a corporate overview at the Goldman Sachs Twenty-Seventh Annual Global Healthcare Conference in Dana Point, California.
